G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 113 filers reported holding G1 THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.83 and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 856,798 | $10,701,000 | 2.53% |
| Paradigm Biocapital Advisors LP | 884,574 | $11,048,000 | 1.47% |
| CHI Advisors LLC | 323,945 | $4,046,000 | 1.09% |
| EAM Investors, LLC | 223,654 | $2,793,000 | 0.61% |
| EAM Global Investors LLC | 133,203 | $1,664,000 | 0.44% |
| Alpha DNA Investment Management LLC | 42,477 | $530,000 | 0.44% |
| Rhenman & Partners Asset Management AB | 370,000 | $3,944,000 | 0.41% |
| Birchview Capital, LP | 40,000 | $500,000 | 0.35% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 134,000 | $1,673,000 | 0.33% |
| Tekla Capital Management LLC | 423,869 | $5,294,000 | 0.22% |